Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12781189rdf:typepubmed:Citationlld:pubmed
pubmed-article:12781189lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:12781189lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:12781189lifeskim:mentionsumls-concept:C2746042lld:lifeskim
pubmed-article:12781189lifeskim:mentionsumls-concept:C1554963lld:lifeskim
pubmed-article:12781189pubmed:issue12lld:pubmed
pubmed-article:12781189pubmed:dateCreated2003-6-3lld:pubmed
pubmed-article:12781189pubmed:abstractTextSynthesis of thrombin inhibitors and their binding mode to thrombin is described. Modification of the P1 moiety leads to an increased selectivity versus trypsin. The observed selectivity is discussed in view of their thrombin-inhibitor complex X-ray structures.lld:pubmed
pubmed-article:12781189pubmed:languageenglld:pubmed
pubmed-article:12781189pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781189pubmed:citationSubsetIMlld:pubmed
pubmed-article:12781189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781189pubmed:statusMEDLINElld:pubmed
pubmed-article:12781189pubmed:monthJunlld:pubmed
pubmed-article:12781189pubmed:issn0960-894Xlld:pubmed
pubmed-article:12781189pubmed:authorpubmed-author:HornbergerWil...lld:pubmed
pubmed-article:12781189pubmed:authorpubmed-author:LangeUdo E...lld:pubmed
pubmed-article:12781189pubmed:authorpubmed-author:MackHelmutHlld:pubmed
pubmed-article:12781189pubmed:authorpubmed-author:SeitzWernerWlld:pubmed
pubmed-article:12781189pubmed:authorpubmed-author:BauckeDoritDlld:pubmed
pubmed-article:12781189pubmed:authorpubmed-author:HöffkenH...lld:pubmed
pubmed-article:12781189pubmed:issnTypePrintlld:pubmed
pubmed-article:12781189pubmed:day16lld:pubmed
pubmed-article:12781189pubmed:volume13lld:pubmed
pubmed-article:12781189pubmed:ownerNLMlld:pubmed
pubmed-article:12781189pubmed:authorsCompleteYlld:pubmed
pubmed-article:12781189pubmed:pagination2029-33lld:pubmed
pubmed-article:12781189pubmed:meshHeadingpubmed-meshheading:12781189...lld:pubmed
pubmed-article:12781189pubmed:meshHeadingpubmed-meshheading:12781189...lld:pubmed
pubmed-article:12781189pubmed:meshHeadingpubmed-meshheading:12781189...lld:pubmed
pubmed-article:12781189pubmed:meshHeadingpubmed-meshheading:12781189...lld:pubmed
pubmed-article:12781189pubmed:meshHeadingpubmed-meshheading:12781189...lld:pubmed
pubmed-article:12781189pubmed:meshHeadingpubmed-meshheading:12781189...lld:pubmed
pubmed-article:12781189pubmed:meshHeadingpubmed-meshheading:12781189...lld:pubmed
pubmed-article:12781189pubmed:meshHeadingpubmed-meshheading:12781189...lld:pubmed
pubmed-article:12781189pubmed:meshHeadingpubmed-meshheading:12781189...lld:pubmed
pubmed-article:12781189pubmed:year2003lld:pubmed
pubmed-article:12781189pubmed:articleTitleD-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety.lld:pubmed
pubmed-article:12781189pubmed:affiliationBASF AG, D-67056, Ludwigshafen, Germany. wolfgang.hoeffken@basf-ag.delld:pubmed
pubmed-article:12781189pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:12781189lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12781189lld:pubmed